QBFM
TEVA icon

QS Batterymarch Financial Management’s Teva Pharmaceuticals TEVA Stock Holding History

QS Batterymarch Financial Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$9.21M Buy
171,325
+626
+0.4% +$33.2K 0.24% 119
2014
Q2 		$8.95M Buy
170,699
+168,943
+9,621% +$8.64M 0.23% 125
2014
Q1 		$93K Sell
1,756
-470
-21% -$21.7K ﹤0.01% 1011
2013
Q4 		$90K Buy
2,226
+490
+28% +$19.3K ﹤0.01% 1011
2013
Q3 		$66K Sell
1,736
-34,700
-95% -$1.35M ﹤0.01% 1033
2013
Q2 		$1.43M Buy
+36,436
New +$1.42M 0.03% 571

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

QS Batterymarch Financial Management's TEVA Position: Q3 2014 in Review

QS Batterymarch Financial Management increased its Teva Pharmaceuticals (TEVA) stake by 0.37% in Q3 2014, buying an estimated $33.2K and bringing the position to 171,325 shares worth $9.21M. The position accounts for 0.24% of the portfolio, ranked #119.

QS Batterymarch Financial Management first reported a position in TEVA in Q2 2013 and has held it in 6 quarters since. 772 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

  • QS Batterymarch Financial Management held 171,325 shares of Teva Pharmaceuticals worth $9.21M as of Q3 2014.
  • QS Batterymarch Financial Management bought 626 Teva Pharmaceuticals shares in Q3 2014, an estimated $33.2K.
  • Teva Pharmaceuticals made up 0.24% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #119 holding.
  • QS Batterymarch Financial Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
  • 772 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.